HES5 and acute lymphoblastic leukemia: We further analyzed Hes5 methylation status in 17 B-ALL patients who received DAC 75 mg/m2 daily for 7 days on an investigational clinical trial (protocol NCT00349596; Garcia-Manero, in preparation).